Analysts' Top Healthcare Picks: Spruce Biosciences (SPRB), Dermata Therapeutics (DRMA)
TipRanksAug 15, 2023 07:00 ET
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Applied DNA Sciences (APDN) and Dermata Therapeutics (DRMA)
TipRanksMay 17, 2023 07:50 ET
Maxim Adjusts Price Target on Dermata Therapeutics to $4 From $16, Keeps Buy Rating
MT NewswiresMar 23, 2023 09:42 ET
Maxim Group Sticks to Its Buy Rating for Dermata Therapeutics (DRMA)
TipRanksFeb 23, 2023 14:26 ET
Maxim Group Sticks to Its Buy Rating for Dermata Therapeutics (DRMA)
TipRanksAug 19, 2022 14:35 ET
No Data
No Data